Francesco Buccisano
0000-0003-4320-9253
Tor Vergata University
146 papers found
Refreshing results…
Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes
Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia
Prognostic factors for thrombosis-free survival and overall survival in polycythemia vera: A retrospective analysis of 623 PTS With long follow-up
Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia
Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency
The Prognostic Significance of Measurable (“Minimal”) Residual Disease in Acute Myeloid Leukemia
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: The Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry
Treatment of Low-Blast Count AML using Hypomethylating Agents
Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia
Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study
FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance
Should patients with acute myeloid leukemia and measurable residual disease be transplanted in first complete remission?:
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): Phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN
A cluster ofGeotrichum clavatum(Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature
Missing publications? Search for publications with a matching author name.